CHINA MARKET-Takeda and Sanofi Sign Co-promotion Agreement to Expand Reach of Diabetes Treatment Alogliptin in China

29 04 2013

New Drug Approvals

ALOGLIPTIN

22.04.2013

• Alogliptin is a DPP-4 inhibitor that is designed to slow the inactivation of incretin hormones GLP-1 and GIP
• Agreement is part of Takeda’s strategy to complement capabilities through partnerships
• Agreement complements Sanofi’s diabetes portfolio and expand its offer of innovative diabetes treatment to Chinese patients
• The regulatory approval of alogliptin in China is expected in 2013

Shanghai, China, April 22, 2013 – Takeda and Sanofi today announced that they have entered into an agreement for the co-promotion of alogliptin in China for the treatment of type 2 diabetes. Alogliptin is Takeda’s new type 2 diabetes therapy, which has been filed for marketing authorization in China. It is a dipeptidyl peptidase-4 inhibitor (DPP-4i) that is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).

Under the terms of the agreement, Takeda will grant Sanofi the exclusive right to co-promote alogliptin in China…

View original post 874 more words

Advertisements

Actions

Information

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Medical Revolt

One Doctor's Open Minded Views on Natural Medicine

pharmupdates.wordpress.com/

News and articles on the Pharmaceutical Industry

Biotech Patent Expert Lawyer India| IPR International Medical Law Firm in India Delhi|Patent Attorneyl Research Services| Patent Portfolio Analytics | Freedom to Operate FTO| Tech Monitoring Service| Patent Services Offshoring | Patent Research Outsourcing | Intellectual Property Services | India Patent Filling

Biotech Patent Lawyer India l Patent Support Offshoring | Patent Research Outsourcing Firm in India| PCT Patent Filing IPR Law Firm New Delhi| Drug Law Practice: Indian Granted Patents Search Expert for Medical, Pharmaceutical, Food & Life Sciences Inventions

The Alien Biologist Daily

Just another WordPress.com weblog

Syntheticnature

Total Synthesis and general organic chemistry

Cheersical Education

All things chemical education: research, practice, theory, and more.

SreetamaDutt's MedMicro Blog

Being geeky for a change and keeping up with the microbial fraternity!

Chemtips

Because Organic Chemistry is Hard Enough

A Word in Your Ear

Stories and Photographs of my travels, Tales of friends, family, animals and my life

DRUG REGULATORY AFFAIRS INTERNATIONAL

Drug Regulatory affairs by DR ANTHONY MELVIN CRASTO, Worlddrugtracker

Orphan Druganaut Blog

PROVIDING COMPETITIVE INTELLIGENCE, NEWS, INTERNET BUZZ ON GLOBAL ORPHAN DRUG DEVELOPMENTS & RARE DISEASES

The Nerdly Painter

Art with a sneaky science flavor

Spa-Dress

Everything we love: Spa, products, travel, health, beauty, make-up, and MORE...

Chemical connections

...chemistry & other curiosities

Tell Me Where To Go

Satisfying my own wanderlust through others

Africa is a Country

a site of media criticism, analysis and new writing

What's for Dinner Ma?

Food. Fitness. Fashion.

%d bloggers like this: